Tamoxifen Wards Off Breast Cancer’s Return for More Than a Decade (HealthDay)

HealthDay – THURSDAY, July 28 (HealthDay News) — Women who took the
cancer-suppressing drug tamoxifen for five years after a breast cancer
diagnosis were nearly 40 percent less likely to have the cancer return,
and that protection lasted for more than a decade after they stopped
taking the drug, a new study finds.